top of page
Search Results

162 items found for "Chris Tate"

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    Get ready to stay up-to-date with the latest research, advancements, and news in the field. From the scientist’s view: a conversation with … Chris Tate AI is dreaming up drugs that no one has ever

  • Dr. GPCR Virtual Cafe with Matthew Eddy - New date!

    ☕ We are excited to announce our rescheduled Dr. GPCR Virtual Cafe session with Dr. Matthew E. on Friday, October 7th at 1 PM ET. Don't miss the chance to listen to his latest research on the field. It's a great opportunity to get warmed up for the upcoming Summit starting the next Monday. Get your ticket today on Eventbrite! ➡https://bit.ly/3CmntVn

  • A central alarm system that gates multi-sensory innate threat cues to the amygdala

    September 2022 "Perception of threats is essential for survival. Previous findings suggest that parallel pathways independently relay innate threat signals from different sensory modalities to multiple brain areas, such as the midbrain and hypothalamus, for immediate avoidance. Yet little is known about whether and how multi-sensory innate threat cues are integrated and conveyed from each sensory modality to the amygdala, a critical brain area for threat perception and learning. Here, we report that neurons expressing calcitonin gene-related peptide (CGRP) in the parvocellular subparafascicular nucleus in the thalamus and external lateral parabrachial nucleus in the brainstem respond to multi-sensory threat cues from various sensory modalities and relay negative valence to the lateral and central amygdala, respectively. Both CGRP populations and their amygdala projections are required for multi-sensory threat perception and aversive memory formation. The identification of unified innate threat pathways may provide insights into developing therapeutic candidates for innate fear-related disorders." Read more at the source #DrGPCR #GPCR #IndustryNews

  • InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...

    February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to

  • Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor

    Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and modulates intracellular binding partner is bound, in which case the receptor is only stabilized in an intermediate-active state

  • Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR

    Our previous Markov State Model (MSM) analysis of molecular dynamics simulations of membrane-embedded

  • Posttranslational modifications in GPCR internalization

    analyzes their significance in GPCR internalization dynamics, internalization routes, postinternalization fates

  • Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...

    The conformational landscapes analyzed by Markov state models revealed that the overall conformation

  • Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...

    generation • Mid-term global expansion plans include drug discovery technology investments, licensing late-stage Chris Cargill appointed as President and Chief Executive Officer • Dr.

  • 📰 GPCR Weekly News, October 9 to 15, 2023

    Read about the newest discoveries in GPCR research 🙌 Save the dates: November 2 - 4: We're sponsoring success Sosei and PharmEnable extend neurological disease drugs hunt Sosei Heptares’ President & CEO Chris SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024

  • 📰 GPCR Weekly News, October 16 to 22, 2023

    Save the dates: November 2 - 4: We're sponsoring the GPCR Retreat and would love to meet you there! USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses State-dependent Topline Safety and Tolerability Data from Proof-of-Concept Studies Sosei Heptares’ President & CEO Chris SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024

  • Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes

    simulations of G protein-coupled receptor-ligand complexes: Impact of ligand type and receptor activation state Likewise, the relative importance of receptor activation state and ligand function differences have also This study compares performance when docking ligands of varied function into varied GPCR activation states , with higher accuracy expected when docking agonists into active state structures and inverse agonists or antagonists into inactive state structures.

  • 📰 GPCR Weekly News

    INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease Chris

  • Nanobodies: New Dimensions in GPCR Signaling Research

    Some Nbs that have been use for GPCR research are: Nb80: This nanobody stabilized an active-state conformation activation and investigate the role of specific regions in the switching between different conformational states extracellular surface of the Rhodopsin receptor and stabilizes the photo-activated receptor in a ground-state-like G., Choi, H. J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.

  • 📰 GPCR Weekly News, March 11 to 17, 2024

    If you participated in our symposiums, please take a moment to complete this survey. GPCR University Save the date for our upcoming workshop, starting May 9th, 2024, featuring Dr.  Those on the waitlist will be notified first of the course dates, so hurry. Dr. Myers Squibb GPCR Events, Meetings, and Webinars March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • Decoding β-Arrestins: from Structure to function

    and intracellular responses GPCR signaling is a complex process modulated by protein conformational states Probing GPCR and β-Arrestin conformational states: methods and implications The formation of functional complexes involving GPCRs and β-arrestins hinges on their specific conformational states, influenced protein and has evolved to achieve resolutions comparable to X-ray crystallography (García-Nafría, J., & Tate Understanding how specific active conformational states influence the interaction or dissociation of

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    If you attended our 2023 Symposia, please take a moment to complete this survey. Dr. cellular signaling GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism State-dependent Biagon Officially Incorporated In The State Of Illinois Septerna divulges new TSHR antagonists for hyperthyroidism March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • 📰 GPCR Weekly News, October 23 to 29, 2023

    Save the dates: November 17: Join our final Dr. Mobilization Using Propranolol with GPC-100 Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024

  • The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1

    August 2022 "Background and purpose: Vascular tone is regulated by the relative contractile state of Several integrins directly modulate VSMC contraction by regulating calcium influx through L-type voltage-gated

  • 📰 GPCR Weekly News, September 18 to 24, 2023

    Take a few minutes and dive into our GPCR coverage! Our recent Dr. Save the dates: November 2 - 4: We're proud sponsors of the GPCR Retreat and can't wait to meet you there SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    Additionally, if you participated in our Symposia in 2023, please take a moment to fill out this survey Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • 📰 GPCR Weekly News, January 1 to 7, 2024

    Save the dates: February 8 - 29: Join Dr. GPCR University's live Zoom sessions hosted by Dr. distinct dependence on arrestins and G proteins A method for structure determination of GPCRs in various states | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • Phosphorylation of RGS regulates MAP kinase localization and promotes completion of cytokinesis

    September 2022 "Yeast use the G-protein–coupled receptor signaling pathway to detect and track the mating We found that pheromone-induced RGS phosphorylation peaks early; the phospho-state of RGS controls its

  • 📰 GPCR Weekly News, May 1 to 7, 2023

    Take a look 👀! Save the date and join us next week, May 19th, 2023 for the Dr. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    Save the date: February 8 - 29: Join Dr. GPCR University's live Zoom sessions hosted by Dr. The GPCR Weekly News will take a holiday break. | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    GPCR University Save the date for our upcoming workshop starting May 9th, 2024, featuring Dr. Those on the waitlist will be the first notified of the course dates, so hurry. Dr. March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |

  • 📰 GPCR Weekly News, October 30 to November 4, 2023

    Take advantage of our GPCR highlights of the week. Dr. lab team developed fluorescent analogues for real-time binding studies of orphan GPCR GPR3: Save the dates SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024

  • Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors

    this lipophilic entry route for 2-iodomelatonin, a nonselective agonist with a slower dissociation rate path-collective variables provided a calculated energy barrier consistent with the experimental dissociation rate Our simulations also suggest that the open state of Tyr5.38 generates a small pocket on the surface of

bottom of page